Taiwan
· Delayed Price · Currency is TWD Synmosa Biopharma Statistics
Total Valuation
TPEX:4114 has a market cap or net worth of TWD 18.10 billion. The enterprise value is 18.73 billion.
| Market Cap | 18.10B |
| Enterprise Value | 18.73B |
Important Dates
The last earnings date was Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Jul 11, 2025 |
Share Statistics
TPEX:4114 has 500.70 million shares outstanding. The number of shares has increased by 2.78% in one year.
| Current Share Class | 500.70M |
| Shares Outstanding | 500.70M |
| Shares Change (YoY) | +2.78% |
| Shares Change (QoQ) | +5.87% |
| Owned by Insiders (%) | 9.45% |
| Owned by Institutions (%) | 4.43% |
| Float | 396.62M |
Valuation Ratios
The trailing PE ratio is 23.80.
| PE Ratio | 23.80 |
| Forward PE | n/a |
| PS Ratio | 3.02 |
| PB Ratio | 1.85 |
| P/TBV Ratio | 2.28 |
| P/FCF Ratio | 37.67 |
| P/OCF Ratio | 25.44 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.25, with an EV/FCF ratio of 38.99.
| EV / Earnings | 25.81 |
| EV / Sales | 3.12 |
| EV / EBITDA | 16.25 |
| EV / EBIT | 22.49 |
| EV / FCF | 38.99 |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.26.
| Current Ratio | 2.70 |
| Quick Ratio | 1.83 |
| Debt / Equity | 0.26 |
| Debt / EBITDA | 2.17 |
| Debt / FCF | 5.29 |
| Interest Coverage | 14.40 |
Financial Efficiency
Return on equity (ROE) is 5.99% and return on invested capital (ROIC) is 4.60%.
| Return on Equity (ROE) | 5.99% |
| Return on Assets (ROA) | 4.06% |
| Return on Invested Capital (ROIC) | 4.60% |
| Return on Capital Employed (ROCE) | 7.35% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.46 |
| Inventory Turnover | 1.82 |
Taxes
In the past 12 months, TPEX:4114 has paid 197.17 million in taxes.
| Income Tax | 197.17M |
| Effective Tax Rate | 26.79% |
Stock Price Statistics
The stock price has increased by +16.39% in the last 52 weeks. The beta is 0.01, so TPEX:4114's price volatility has been lower than the market average.
| Beta (5Y) | 0.01 |
| 52-Week Price Change | +16.39% |
| 50-Day Moving Average | 33.64 |
| 200-Day Moving Average | 29.70 |
| Relative Strength Index (RSI) | 50.53 |
| Average Volume (20 Days) | 2,363,819 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:4114 had revenue of TWD 6.00 billion and earned 725.80 million in profits. Earnings per share was 1.52.
| Revenue | 6.00B |
| Gross Profit | 2.62B |
| Operating Income | 848.29M |
| Pretax Income | 735.90M |
| Net Income | 725.80M |
| EBITDA | 1.18B |
| EBIT | 848.29M |
| Earnings Per Share (EPS) | 1.52 |
Balance Sheet
The company has 3.29 billion in cash and 2.54 billion in debt, giving a net cash position of 746.98 million or 1.49 per share.
| Cash & Cash Equivalents | 3.29B |
| Total Debt | 2.54B |
| Net Cash | 746.98M |
| Net Cash Per Share | 1.49 |
| Equity (Book Value) | 9.78B |
| Book Value Per Share | 16.95 |
| Working Capital | 4.27B |
Cash Flow
In the last 12 months, operating cash flow was 711.47 million and capital expenditures -231.00 million, giving a free cash flow of 480.47 million.
| Operating Cash Flow | 711.47M |
| Capital Expenditures | -231.00M |
| Free Cash Flow | 480.47M |
| FCF Per Share | 0.96 |
Margins
Gross margin is 43.68%, with operating and profit margins of 14.15% and 12.11%.
| Gross Margin | 43.68% |
| Operating Margin | 14.15% |
| Pretax Margin | 12.27% |
| Profit Margin | 12.11% |
| EBITDA Margin | 19.69% |
| EBIT Margin | 14.15% |
| FCF Margin | 8.01% |
Dividends & Yields
This stock pays an annual dividend of 0.55, which amounts to a dividend yield of 1.51%.
| Dividend Per Share | 0.55 |
| Dividend Yield | 1.51% |
| Dividend Growth (YoY) | 9.82% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 31.52% |
| Buyback Yield | -2.78% |
| Shareholder Yield | -1.30% |
| Earnings Yield | 4.01% |
| FCF Yield | 2.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on July 11, 2025. It was a forward split with a ratio of 1.099848595.
| Last Split Date | Jul 11, 2025 |
| Split Type | Forward |
| Split Ratio | 1.099848595 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |